AnteoTech Ltd (ASX:ADO)
A$ 0.022 +0.0010 (+4.76%) Market Cap: 71.72 Mil Enterprise Value: 71.91 Mil PE Ratio: 0 PB Ratio: 22.00 GF Score: 0/100

Half Year 2026 Anteotech Ltd Earnings Call Transcript

Mar 1, 2026 / 11:30 PM GMT

Key Points

Positve
  • AnteoTech Ltd (ASX:ADO) has streamlined its cost-based structure, focusing on sales conversion and strategic partnerships.
  • The company has made significant progress in market segmentation and value proposition, particularly with the Ultra Node X product.
  • AnteoTech Ltd has established a solid financial base with a 3.5 million capital raise, providing runway for future projects.
  • The company is actively engaging with potential customers in the US and South Korea, leveraging partnerships and conferences to expand its market reach.
  • The life sciences unit is progressing well, maintaining strong relationships with key partners like the Serum Institute and exploring new product applications.
Negative
  • Revenue recognition was delayed due to the non-dispatch of orders from the Serum Institute, impacting financial results.
  • Progress with WEO and other sales contracts in the clean energy sector has been slower than anticipated, causing frustration among stakeholders.
  • The company faces challenges in converting sales leads into contracts, with a need for more testing and customer engagement.
  • AnteoTech Ltd's share price is trading at a discount to the most recent capital raising, reflecting market concerns.
  • The company is still in the process of enhancing its sales and marketing strategies, including the development of a new website and CRM system.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ADO.AX - Anteotech Ltd
Half Year 2026 Anteotech Ltd Earnings Call
Mar 01, 2026 / 11:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Antiotech's investor briefing following the release of the first half of financial year 2026 report. On the line we have managing director and CEO Merrill Grey, who will go through the presentation up on the screen. Just a reminder, we have had a number of pre-submitted questions. We'll allow a few to be submitted through the Q&A button at the bottom of the screen if we have time to get through them. But with that, Meryl, I'll hand it over to you.

Thank you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much, Simon. First up, I'd
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot